drugset / Trial / NCT01437865
Gadofosveset for Axillary Staging in Breast Cancer Patients
NaSingle-groupOpen-labelDiagnostic
Summary
The aim of this pilot-study is to examine the accuracy of gadofosveset enhanced MRI compared to current nodal staging methods. The accuracy of MRL will be determined on the basis of a node-to-node matching of imaged nodes to the definitive histopathology. The pathologic examination of the SNLB or ALND will be regarded as the golden standard for nodal involvement.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadofosveset | Diagnostic / imaging agent | 0.03 mmol | Intravenous |